By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 115.25 |
Change Today | $ -0.51 |
% Change | -0.44 % |
52 Week High | $121.40 |
52 Week Low | $80.94 |
Volume | 7,839,719 |
Shares Issued | 1,246.00m |
Market Cap | $143,602m |
Beta | 0.01 |
RiskGrade | 120 |
Strong Buy | 9 |
Buy | 12 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
15:59 | 200 @ $115.26 |
15:59 | 380 @ $115.27 |
15:59 | 100 @ $115.26 |
15:59 | 100 @ $115.26 |
15:59 | 100 @ $115.26 |
You are here: research